A first-in-human trial from Institute of Science Tokyo and EVA Therapeutics, Inc., demonstrates that enteral ventilation, a ...
Not What You Think Official on MSN
Why a U-2 pilot opened his helmet at 70,000 feet and somehow lived
U-2 pilots already fly in conditions so extreme that they need pressure suits, pure oxygen, and astronaut-like procedures ...
New J-code for Epioxaâ„¢, J2789, set to become effective July 1, 2026ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company ...
The study found that timely administration of antibiotics and fluids leads to higher patient discharge to home.
Premature infants in NICUs may endure about 14 painful procedures a day; evidence shows these early repeated painful stimuli can intensify pain sensitivity and produce long-term neurobiological harm.
Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...
From the iconic 'Penalty of Leadership' ad to its 2009 bankruptcy, explore how GM's bold vision influenced American culture.
Umuahia South local government, Abia State has delivered a 24-year old woman, Chikamso Ibekwe, of a set of twins (boys) ...
Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't ...
Zacks Investment Research on MSN
Glaukos wins permanent J-code for Epioxa keratoconus therapy
Glaukos GKOS announced that its innovative keratoconus treatment, Epioxa (Epioxa HD / Epioxa), was assigned a permanent HCPCS ...
A man in Siberia was brought back to life after spending more than five hours collapsed in sub-zero temperatures, and being ...
This article argues for the adoption of a combined lyophilized plasma and platelet product strategy to address critical gaps.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results